Evidence map›Paper›PMID 32870676›Full record

ArticleJournal of the American Chemical Society2020

Multiplexed Probing of Proteolytic Enzymes Using Mass Cytometry-Compatible Activity-Based Probes.

Marcin Poreba, Katarzyna M Groborz, Wioletta Rut, Milind Pore, Scott J Snipas, Matej Vizovisek, Boris Turk, Peter Kuhn, Marcin Drag, Guy S Salvesen

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. CyTOFFrontiers in immunology · 2022
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Marcin PorebaSanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States.ORCID 0000-0002-0214-6252
Katarzyna M GroborzSanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States.
Wioletta RutWroclaw University of Science and Technology, Wroclaw, 50-370, Poland.
Milind PoreUniversity of Southern California, USC Michelson Center for Convergent Biosciences, Los Angeles, California 90089, United States.
Scott J SnipasSanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States.
Matej VizovisekJozef Stefan Institute, 1000 Ljubljana, Slovenia.
Boris TurkJozef Stefan Institute, 1000 Ljubljana, Slovenia.ORCID 0000-0002-9007-5764
Peter KuhnUniversity of Southern California, USC Michelson Center for Convergent Biosciences, Los Angeles, California 90089, United States.
Marcin DragSanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States.ORCID 0000-0001-8510-1967
Guy S SalvesenSanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States.ORCID 0000-0002-7933-6732
Wrocław University of Science and Technology · PLJožef Stefan Institute · SISanford Burnham Prebys Medical Discovery Institute · USUniversity of Southern California · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ELENA B PASQUALE · 1985 to 2026
$107.2M
Survival Mechanisms for Apoptotic CaspaseR01GM099040 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI SALVESEN, GUY S. · 2012 to 2020
$3.8M
NCI NIH HHS P30 CA030199NIGMS NIH HHS R01 GM099040
6 · The paper itself

Abstract

The subset of the proteome that contains enzymes in their catalytically active form can be interrogated by using probes targeted toward individual specific enzymes. A subset of such enzymes are proteases that are frequently studied with activity-based probes, small inhibitors equipped with a detectable tag, commonly a fluorophore. Due to the spectral overlap of these commonly used fluorophores, multiplex analysis becomes limited. To overcome this, we developed a series of protease-selective lanthanide-labeled probes compatible with mass cytometry giving us the ability to monitor the activity of multiple proteases in parallel. Using these probes, we were able to identify the distribution of four proteases with different active site geometries in three cell lines and peripheral blood mononuclear cells. This provides a framework for the use of mass cytometry for multiplexed enzyme activity detection.

Indexed as

Cell LineCoordination ComplexesHumansLanthanoid Series ElementsMolecular ProbesMolecular StructurePeptide HydrolasesCoordination ComplexesLanthanoid Series ElementsMolecular ProbesPeptide Hydrolases

Identifiers

PMID32870676
PMCPMC7595764
OpenAlexW3082194919

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.